Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Real Estate Agent Julie Ann Giachetti Recognized as Royal Palm Waterfront Expert
-
CURRENC Group Inc. Appoints Wan Lung Eng as Chief Financial Officer
-
Rent the Runway, Inc. Announces Fourth Quarter and Full Year 2024 Results
-
Premion Expands Omnichannel and Ad Tech Capabilities to Drive Cross-Channel Performance and Fuel Next Growth Phase
-
Qorvo® to Webcast Quarterly Earnings Conference Call on April 29, 2025
-
Ashvattha Therapeutics to Present at ARVO, Retina World Congress, and AOS Annual Meeting
-
Tokenized Luxury at Your Fingertips: KSGEMS Unlocks the $10B Gemstone Market for Everyday Investors
-
Windtree Therapeutics Reports Year-End 2024 Financial Results and Provides Key Business Updates
-
JBTC Announces 1st Quarter 2025 Earnings
-
ISC to Release 2025 First Quarter Financial Results on May 6, 2025
-
FluidForm Bio™ Advances Vascularized Tissue Engineering with New FRESH™ 3D Bioprinting Breakthrough
-
Galectin Therapeutics to Present at the European Association for the Study of the Liver (EASL) 2025 Congress
-
First Onsite Pensacola Expands Biohazard Response Capabilities
-
EllisDon Launches Base Design™ for Canadian Affordable Housing
-
Golden State’s Asset Management Program Expands Offerings and Enhances Advisor Support by Partnering with WealthShield
-
TransGlobal Assets Inc. (OTC: TMSH) and The Now Corporation (OTC: NWPN) Strike Strategic Deal to Commercialize Acclaimed Works by Michael Berman
-
Test Your Environmental Knowledge with Bluedot Living’s Interactive Earth Day Quiz
-
ORYZON Announces First Patient Dosed in NCI-Sponsored Phase I/II Clinical Trial of Iadademstat Plus Immune Checkpoint Inhibitors in 1L Extensive Stage Small Cell Lung Cancer
-
Microchip Launches High-Reliability BR235 and BR235D Series of Power Relays for Demanding Military Applications
-
IPG Photonics to Announce First Quarter 2025 Financial Results on May 6
-
Pipe Acquires Glean.ai to Add Spend Management to Suite of Embedded Financial Solutions
-
Neuphoria Provides a Review of 2024 and Highlights 2025 Plans
-
REGIONAL HEALTH PROPERTIES AND SUNLINK HEALTH SYSTEMS REVISE ALL-STOCK MERGER TRANSACTION
-
ASP Isotopes Inc. Announces Changes in Boards of ASP Isotopes Inc. and Quantum Leap Energy LLC
-
Trump Media Launches Separately Managed Accounts
-
Aspargo Labs CEO to Participate in Panel Discussion at the American Urological Association Innovation Nexus Conference
-
AgEagle Showcases eBee VISION Drone at 173rd Airborne Brigade Innovation Symposium
-
Chemomab Announces New Medical and Clinical Appointments
-
Aqua Metals Develops Nickel Carbonate Product to Expand Market Reach and Maximize Process Efficiency
-
FDA Clears Ceribell’s Clarity™ Algorithm for Pediatric Patients, Making Ceribell the First and Only FDA-Cleared AI Technology for Detection of Electrographic Seizures in Patients Ages 1 Year and O
-
Tectonic Therapeutic to Present Phase 1b Data for TX45 at European Society of Cardiology Heart Failure 2025
-
Brera Holdings Celebrates Inaugural LOVB Pro Volleyball Championship as Former UYBA Stars Lead Austin to Historic Victory Over Omaha
-
Janover Purchases Approximately $10.5 Million of Solana (SOL) as Part of New Treasury Strategy
-
zSpace Acquires Second Avenue Learning to Revolutionize Experiential Education
-
Alignment Healthcare Strengthens Leadership to Scale its AI-Enabled Medicare Advantage Platform with Two Key Appointments
-
Sunrise Realty Trust Schedules Earnings Release and Conference Call for the First Quarter Ending March 31, 2025
-
Mural Oncology Announces Plans to Explore Strategic Alternatives
-
Greystone Logistics Reports 3rd Quarter Earnings
-
Combating Document Fraud and Transnational Crime: Lao PDR Airport Deploys Regula 4306 Comparator
-
RAPT Therapeutics Deepens Expertise in Allergic Diseases with Appointment of Jessica Savage, M.D., M.H.S., as Vice President, Clinical Development
-
Advanced Flower Capital Schedules Earnings Release and Conference Call for the First Quarter Ending March 31, 2025
-
New Research at ACC25 Shows Daxor BVA-Identified Euvolemic Heart Failure Patients Experience 2.61 Times Better Survival
-
Processa Pharmaceuticals’ Dr. David Young to Present at World Orphan Drug Congress USA 2025
-
Rezolve Ai Secures $9.8 Million Annual Contract with Liverpool Mexico
-
Hydreight Technologies Expands GLP-1 Telehealth Suite with Launch of Liraglutide on VSDHOne Platform
-
Extendicare Announces April 2025 Dividend of C$0.042 per Share
-
Basetwo Wins Top Prize at CIX Summit 2025, Selected for Startup World Cup
-
Avalon GloboCare Partners with SpecialtyHealth, Inc. to Power Police Chiefs’ Fitness Challenge with KetoAir
-
Lisata Therapeutics Announces Research License with Catalent
-
Intermex Empowers Store Owners With Launch of Intermex SOMA: A Game-Changing Mobile App for Business Management on the Go

